Correspondence 0001493152-23-026315 from Vitro Biopharma, Inc. (VTRO) (CIK 0000793171)
Vitro Biopharma, Inc. (VTRO) (CIK 0000793171)
Date: Aug. 1, 2023 · CIK: 0000793171 · Accession: 0001493152-23-026315
AI Filing Summary & Sentiment
File numbers found in text: 333-267366
Show Raw Text
CORRESP
1
filename1.htm
ThinkEquity
LLC
17
State Street, 41st Floor
New
York, New York 10004
August
1, 2023
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Attn:
Joshua Gorsky, Suzanne Hayes, Julie Sherman and Kevin Vaughn
Re:
Vitro
Biopharma, Inc. (the “Company”)
Registration
Statement on Form S-1, as amended (File No. 333-267366)
Withdrawal
of Request for Acceleration of Effectiveness
Ladies
and Gentlemen:
On
July 31, 2023, ThinkEquity LLC, as representative of the underwriters, requested acceleration of the effective date of the above-referenced
Registration Statement so that it would become effective at 5:00 p.m. Eastern Time, on Wednesday, August 2, 2023, or as soon thereafter
as practicable. We hereby withdraw such request.
Very truly yours,
ThinkEquity LLC
By:
/s/
Kevin Mangan
Name:
Kevin
Mangan
Title:
Managing Director, Head of Equity Syndicate
cc:
Leslie Marlow, Esq., Blank
Rome LLP
Patrick
J. Egan, Esq., Blank Rome LLP